SMARCB1 and neoplasm: In the context of SMARCB1 mutations or SS18 fusion proteins, ncBAF complex activity is increased and compensates for the loss of cBAF and PBAF function; hence, SMARCB1 mutant tumor cells are explicitly vulnerable to perturbation of ncBAF activity.247, 248, 249